ATOM vs UTHR · rev $135.0K vs P/E 20, rev $2.88B
Atomera Inc (ATOM) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Atomera Inc (ATOM) is a semiconductor equipment & materials company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ATOM revenue for 2024-12-31 was $135.0K. Net income was -$18.4M. Revenue was down 75.5% from 2023-12-31 to 2024-12-31. ATOM currently screens at market cap $341.1M.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
ATOM currently screens at market cap $341.1M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the ATOM and UTHR stock pages for the full models.
Not investment advice.